tiprankstipranks
Trending News
More News >
Grand Pharmaceutical Group Limited (HK:0512)
:0512
Hong Kong Market

Grand Pharmaceutical Group Limited (0512) Income Statement

Compare
5 Followers

Grand Pharmaceutical Group Limited Income Statement

Last quarter (Q2 2025), Grand Pharmaceutical Group Limited's total revenue was HK$6.11B, an increase of 1.97% from the same quarter last year. In Q2, Grand Pharmaceutical Group Limited's net income was HK$1.17B. See Grand Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
HK$ 11.64BHK$ 10.53BHK$ 9.56BHK$ 8.60BHK$ 6.35B
Gross Profit
HK$ 6.74BHK$ 6.52BHK$ 5.95BHK$ 5.25BHK$ 4.04B
Operating Expenses
HK$ 4.57BHK$ 3.86BHK$ 3.43BHK$ 3.23BHK$ 2.53B
Depreciation and Amortization
HK$ 503.75MHK$ 392.21MHK$ 394.91MHK$ 339.52MHK$ 287.06M
EBITDA
HK$ 3.39BHK$ 2.97BHK$ 3.09BHK$ 3.10BHK$ 2.41B
Operating Income
HK$ 2.17BHK$ 2.66BHK$ 2.52BHK$ 2.02BHK$ 1.51B
Other Income/Expenses
HK$ 680.33MHK$ -319.20MHK$ -731.00KHK$ 767.25MHK$ 564.31M
Pretax Income
HK$ 2.85BHK$ 2.34BHK$ 2.52BHK$ 2.79BHK$ 2.07B
Net Income
HK$ 2.47BHK$ 1.88BHK$ 2.08BHK$ 2.40BHK$ 1.79B
Per Share Metrics
Basic EPS
HK$ 0.70HK$ 0.54HK$ 0.59HK$ 0.68HK$ 0.52
Diluted EPS
HK$ 0.70HK$ 0.54HK$ 0.59HK$ 0.68HK$ 0.52
Weighted Average Shares Outstanding
3.50B 3.51B 3.54B 3.55B 3.45B
Weighted Average Shares Outstanding (Diluted)
3.50B 3.51B 3.54B 3.55B 3.45B
Currency in HKD

Grand Pharmaceutical Group Limited Earnings and Revenue History